Position in RYTM
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$888
-$242 QoQ
Shares Held
8
-38.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#286
of 299 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bare Financial Services, Inc holds $305,722 across 81 Biotechnology names. RYTM ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
72 | $26,759 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
78 | $24,654 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
294 | $23,980 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
186 | $22,799 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
398 | $21,865 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
218 | $17,769 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
165 | $9,441 | |
| 8 | INCY |
Incyte Corp
|
83 | $9,408 |
All Filings in RYTM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $888 | 8 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,130 | 13 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,354 | 22 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,817 | 18 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $631 | 10 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||